Evidence map›Paper›PMID 30135695›Full record

ArticleFrontiers in plant science2018

The Integration of Science and Policy in Regulatory Decision-Making: Observations on Scientific Expert Panels Deliberating GM Crops in Centers of Diversity.

Karen E Hokanson, Norman Ellstrand, Alan Raybould

Abstract read
In one paragraph

Article in Frontiers in plant science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Conducting fit-for-purpose food safety risk assessments.EFSA journal. European Food Safety Authority · 2019
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karen E HokansonDepartment of Horticultural Science, University of Minnesota, St. Paul, MN, United States.
Norman EllstrandDepartment of Botany and Plant Sciences, University of California, Riverside, Riverside, CA, United States.
Alan RaybouldRegulatory Science, Syngenta Crop Protection AG, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Panels of experts with specialized knowledge and experience are often convened to identify and analyze information relevant for risk assessments of GM crops. A perspective on the use of such scientific expert panels is shared here based on panels convened to inform the regulatory strategy for three separate projects developing GM crops for cultivation in Africa: a nutritionally enhanced sorghum, an insect resistant cowpea, and a virus resistant cassava. The panels were convened specifically to consider the risks associated with gene flow from a genetically modified (GM) crop to naturally occurring 'wild' relatives of that crop. In these cases, the experts used problem formulation to identify effects that regulatory authorities may consider to be harmful ("harms") and formulate plausible scenarios that might lead to them, and the availability of information that could determine the likelihood of the steps in the pathway. These panels and the use of problem formulation worked well to gather the existing information and consider the likelihood of harm from gene flow in centers of diversity. However, one important observation from all of these cases is that it is outside the remit of such scientific expert panels to make decisions dependent on policy, such as which harms should be considered and what information should be considered essential in order for a regulatory authority to make a decision about the acceptable level of risk. These experiences of expert panels to inform GM crop risk assessment demonstrate the challenge of integrating science and policy for effective regulatory decision-making.

Indexed as

centers of diversityexpert panelsgene flowGM crop regulationproblem formulationrisk assessmentrisk characterization

Identifiers

PMID30135695
PMCPMC6092496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.